Delayed accumulation of the yeast G1 cyclins Cln1 and Cln2 and the F-box protein Grr1 in response to glucose.

Yeast

School of Medicine, Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR 97239, USA.

Published: May 2007

The ability to integrate nutrient availability into cell cycle regulation is critical for the viability of organisms. The Saccharomyces cerevisiae ubiquitin ligase SCF(Grr1) regulates the stability of several proteins that participate in cell division or nutrient sensing. Two of its targets, the cyclins Cln1 and Cln2, accumulate in the presence of glucose. When glucose is added to cells growing asynchronously, we show that the accumulation of the cyclins is a very slow response. We report that the F-box protein Grr1 also accumulates at higher levels in the presence of glucose, and that the response to glucose follows a delayed pattern strikingly similar to that described for Cln1 and Cln2. A model for the regulation of F-box proteins predicts that substrate accumulation could stabilize Grr1. While we found that Grr1 is more stable in cells growing with glucose, we show that the delayed responses to glucose occur independently: Grr1 accumulates in the absence of the cyclins, and vice versa. Thus, our results indicate that this model might not apply to the cyclins and Grr1. Glucose is known to strengthen the interaction of Grr1 with Skp1 in the SCF complex. We hypothesize that glucose could promote the accumulation of Grr1 and its assembly into a SCF complex as a feedback regulation that helps compensate for higher cyclins levels.

Download full-text PDF

Source
http://dx.doi.org/10.1002/yea.1472DOI Listing

Publication Analysis

Top Keywords

cln1 cln2
12
glucose
9
cyclins cln1
8
f-box protein
8
grr1
8
protein grr1
8
response glucose
8
presence glucose
8
cells growing
8
grr1 accumulates
8

Similar Publications

Children with neurodegenerative disease often have debilitating gastrointestinal symptoms. We hypothesized that this may be due at least in part to underappreciated degeneration of neurons in the enteric nervous system (ENS), the master regulator of bowel function. To test this hypothesis, we evaluated mouse models of neuronal ceroid lipofuscinosis type 1 and 2 (CLN1 and CLN2 disease, respectively), neurodegenerative lysosomal storage disorders caused by deficiencies in palmitoyl protein thioesterase-1 and tripeptidyl peptidase-1, respectively.

View Article and Find Full Text PDF

Objective: To unravel the clinical and genetic specifications of Neuronal ceroid lipofuscinosis (NCL).

Methods: This is a retrospective cross-sectional study conducted in the Department of Pediatric Neurology Children Hospital and University of Child Health Sciences, Lahore, Pakistan from March 2017 to March 2022. The primary outcome was to measure genotype-phenotype correlation by segregation of phenotypes according to genotype.

View Article and Find Full Text PDF

Whi5 hypo- and hyper-phosphorylation dynamics control cell-cycle entry and progression.

Curr Biol

June 2024

Department of Biology, Stanford University, 327 Campus Dr., Stanford, CA 94305, USA; Chan Zuckerberg Biohub, 499 Illinois St., San Francisco, CA 94158, USA. Electronic address:

Progression through the cell cycle depends on the phosphorylation of key substrates by cyclin-dependent kinases. In budding yeast, these substrates include the transcriptional inhibitor Whi5 that regulates G1/S transition. In early G1 phase, Whi5 is hypo-phosphorylated and inhibits the Swi4/Swi6 (SBF) complex that promotes transcription of the cyclins CLN1 and CLN2.

View Article and Find Full Text PDF

Developmental Skills and Neurorehabilitation for Children With Batten Disease: A Retrospective Chart Review of a Comprehensive Batten Clinic.

Pediatr Neurol

March 2024

Division of Neurology, Nationwide Children's Hospital, Nationwide Children's Hospital Batten Disease Center for Excellence, The Ohio State University, Columbus, Ohio.

Article Synopsis
  • Batten disease is a rare neurogenetic disorder primarily affecting children, characterized by symptoms like seizures, vision loss, and developmental delays, and neurorehabilitation can enhance the quality of life for affected families.
  • A study of 70 children with various Batten disease subtypes revealed significant impairments in vision (61%), seizures (68%), and skills like fine motor (65%) and language (83%), with most receiving weekly neurorehabilitation services.
  • The findings highlight the need for individualized rehabilitation plans based on clinical features and family preferences, alongside efforts to develop standardized dosing and outcome assessments for effective neurorehabilitation services.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!